Clinical Trials Directory

Trials / Unknown

UnknownNCT03432468

Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women

Effect of Fully Blocking Type 1 Angiotensin Receptor on Blood Pressure, Cardiac Structure, Cardiac Function and Cognitive Function in Postmenopausal Hypertensive Women

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
102 (estimated)
Sponsor
LanZhou University · Academic / Other
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study compared the improvements of blood pressure levels, left ventricular hypertrophy, left ventricular diastolic function, vascular function and cognitive function between postmenopausal hypertensive women and age-matched hypertensive male patients through the evaluation of the effects of fully blocked AT1 receptor by valsartan. Additionally, the differences of the above indexes between the patients who were fully blocked AT1 receptor by valsartan and the patients who were treated with a single dose of valsartan treatment were assessed, so as to provide theory basis for clinical treatment of postmenopausal hypertensive women.

Conditions

Interventions

TypeNameDescription
DRUGValsartan 1the high dose of valsartan
DRUGValsartan 80 mga single dose of valsartan

Timeline

Start date
2018-04-01
Primary completion
2019-08-01
Completion
2019-08-01
First posted
2018-02-14
Last updated
2018-03-13

Source: ClinicalTrials.gov record NCT03432468. Inclusion in this directory is not an endorsement.